NDAOPHTHALMICSOLUTION/DROPS
Approved
Jan 1996
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Drug data last refreshed 7h ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
VISINE is a fixed-dose combination ophthalmic solution containing naphazoline hydrochloride (a decongestant) and pheniramine maleate (an antihistamine) for topical eye use. It is indicated for temporary relief of itching and redness due to allergic conjunctivitis, hay fever, or minor eye irritation. The naphazoline works as a vasoconstrictor to reduce redness while pheniramine provides antihistamine relief from itching.
LOE Approaching
As an OTC product approaching patent expiry with moderate competitive pressure (30% intensity), VISINE brand teams face declining exclusivity and require defensive marketing strategies focused on consumer awareness and brand loyalty.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
VISINE offers limited career growth potential given its LOE-approaching status and zero linked job postings; roles tend to be maintenance-focused rather than development-focused. Professionals joining this brand should expect responsibility for protecting market share, optimizing retail placement, and managing competitive pricing rather than launching innovation or expanding clinical indications.
Brand Manager
Worked on VISINE at Alcon? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.